Quantum Biopharma (QNTM) Short Interest Ratio & Short Volume

Short interest is the volume of Quantum Biopharma shares that have been sold short but have not yet been covered or closed out. As of September 15th, traders have sold 61,800 shares of QNTM short. Learn More on Quantum Biopharma's current short interest.

Quantum Biopharma saw a increase in short interest in the month of September. As of September 15th, there was short interest totaling 61,800 shares, an increase of 27.7% from the previous total of 48,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Quantum Biopharma: Heron Therapeutics, Inc. (17.98%), Atea Pharmaceuticals, Inc. (9.55%), Zura Bio Limited (1.12%), Tonix Pharmaceuticals Holding Corp. (15.18%), Sagimet Biosciences Inc. (11.90%), Ventyx Biosciences, Inc. (7.17%), ProQR Therapeutics N.V. (1.15%), Entrada Therapeutics, Inc. (4.73%), Lunai Bioworks Inc. (0.82%), Cabaletta Bio, Inc. (6.09%),

As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Corporation ($8.81 billion), Canadian Natural Resources Limited ($5.82 billion), Reddit Inc. ($5.19 billion), Coinbase Global, Inc. ($4.52 billion), Robinhood Markets, Inc. ($4.30 billion), Charter Communications, Inc. ($3.75 billion), CoreWeave Inc. ($3.66 billion), Seagate Technology Holdings PLC ($3.57 billion), Live Nation Entertainment, Inc. ($3.33 billion), and Rocket Lab Corporation ($3.26 billion). View all of the most shorted stocks.

Short selling QNTM is an investing strategy that aims to generate trading profit from Quantum Biopharma as its price is falling. QNTM shares are trading up $0.35 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Quantum Biopharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of QNTM, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including QNTM, twice per month. The most recent reporting period available is September, 15 2025.